All In MedTech

FDA Clearance Tracker · P140011

MAMMOMAT INSPIRATION WITH TOMOSYNTHESIS OPTION

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 19, 2026Latest source record: Apr 21, 2015 (this decision)Source: openFDAMethods & limitations

PMA

Decided

Apr 21, 2015

Approved

Time to decision

299 days

Received Jun 26, 2014. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P140011
Device name
MAMMOMAT INSPIRATION WITH TOMOSYNTHESIS OPTION
Applicant location
Mavern, PA
Received
Jun 26, 2014
Decided
Apr 21, 2015
Decision
Approved
Supplements
8 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code OTE

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE MAMMOMAT INSPIRATION WITH TOMOSYNTHESIS OPTION. THIS DEVICE IS INDICATED FOR THE ACQUISITION OF 2D AS WELL AS 3D DIGITAL MAMMOGRAPHY IMAGES TO BE USED IN SCREENING AND DIAGNOSIS OF BREAST CANCER. EACH SCREENING EXAMINATION MAY CONSIST OF CC AND MLO VIEWS IN: A 2D IMAGE SET, OR A 2D AND 3D IMAGE SET. NOTE: THE SCREENING EXAMINATION MAY CONSIST OF 2D FFDM IMAGES SET WITH OR WITHOUT THE 3D IMAGE SET.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code OTE. The earliest in FDA's data is P080003, decided Feb 11, 2011.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Siemens Medical Solutions USA, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.